
|
|
|
| For 100 years, C. R. Bard, Inc. has committed its resources to creating innovative products and services that meet the needs of healthcare providers and patients. Today, BARD is a worldwide leader in products that focus on Disease State Management in three key areas: Vascular, Urology and Oncology. To complement these areas, BARD has a complete line of advanced Surgical Specialty Products and Services. |
|
Please note that the information in each of the above press releases is only current as of the date of the release. C. R. Bard, Inc. undertakes no obligation to update the information in the press releases to reflect new information, the occurrence of future events or circumstances, or otherwise. |
|
|
Fluency® Plus
Tracheobronchial Stent Graft
The new FLUENCY® Plus Tracheobronchial Stent Graft from Bard represents the perfect balance of desirable device characteristics: excellent radial strength, high visibility, flexibility, minimal foreshortening, placement accuracy, low delivery system profile, and convenient deployment with an easy-to-use pullback delivery system.
|